Thiopurine-S-methyltransferase genotype and the response to azathioprine in inflammatory bowel disease

被引：5
|
作者：
Stocco, G. [1 ]
Martelossi, S.
Decorti, G.
Bartoli, F.
Ventura, A.
机构：
[1] Univ Trieste, Dept Biomed Sci, Trieste, Italy
[2] Univ Trieste, IRCCS Burlo Garofolo, Dept Reprod & Dev Sci, Trieste, Italy
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2007年 / 26卷 / 07期
关键词：
D O I：
10.1111/j.1365-2036.2007.03417.x
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1083 / 1084
页数：2
相关论文
共 50 条
  • [31] Thiopurine S-methyltransferase (TPMT) genotype does not predict adverse drug reactions to thiopurine drugs in patients with inflammatory bowel disease
    Gearry, RB
    Barclay, ML
    Burt, MJ
    Collett, JA
    Chapman, BA
    Roberts, RL
    Kennedy, MA
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 18 (04) : 395 - 400
  • [32] Thiopurine Methyltransferase and Inosine Triphosphate Pyrophosphohydrolase Genotypes Among Patients With Inflammatory Bowel Disease Treated With Azathioprine
    Aljudaibi, Bandar
    Gregor, James C.
    Chande, Nilesh
    Kim, Richard B.
    Ponich, Terry P.
    Schwarz, Ute I.
    GASTROENTEROLOGY, 2011, 140 (05) : S294 - S294
  • [33] Relevance of thiopurine methyltransferase activity in inflammatory bowel disease patients maintained on low-dose azathioprine
    Campbell, S
    Kingstone, K
    Ghosh, S
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (03) : 389 - 398
  • [34] Gastrointestinal side effects of azathioprine in patients with inflammatory bowel disease are not related to thiopurine methyltransferase polymorphism.
    Kaskas, BA
    SchSffeler, E
    Lang, T
    Zanger, U
    Marx, C
    Fischer, C
    Eichelbaum, M
    Gregor, M
    Schwab, M
    GASTROENTEROLOGY, 2000, 118 (04) : A787 - A787
  • [35] Thiopurine methyltransferase activity and myelosuppression in inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine
    Gisbert, JP
    Luma, M
    Maté, J
    González-Guijarro, L
    Cara, C
    Pajares, JM
    MEDICINA CLINICA, 2003, 121 (01): : 1 - 5
  • [36] TPMT genotype and the response to azathioprine in inflammatory bowel disease: authors' reply
    Winter, J. W.
    Marinaki, A. M.
    Sanderson, J. D.
    Mills, P. R.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 (07) : 1084 - 1085
  • [37] Thiopurine Methyltransferase, Inosine Triphosphate Pyrophosphohydrolase and Glutathione S Transferases Genotypes Among Patients With Inflammatory Bowel Disease Treated With Azathioprine
    Aljudaibi, Bandar
    Schwarz, Ute I.
    Kim, Richard B.
    Dresser, George K.
    Ponich, Terry P.
    Chande, Nilesh
    Gregor, James C.
    Huda, Noureen
    GASTROENTEROLOGY, 2012, 142 (05) : S383 - S383
  • [38] Azathioprine, 6-mercaptopurine and thiopurine s-methyltransferase levels in inflammatory bowel disease: what is current clinical practice?
    Siriwardana, A. S.
    Koo, J. H.
    Ng, W. S. W.
    Connor, S. J.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A311 - A312
  • [39] Thiopurine S-methyltransferase activity in inflammatory bowel disease: A retrospective study
    Hassan, C
    Duley, J
    Ansari, A
    Shobowale-Bakre, EM
    Reffitt, D
    Meenan, J
    Sanderson, J
    GASTROENTEROLOGY, 1999, 116 (04) : A733 - A733
  • [40] Genetically-determined misfolding and degradation of thiopurine-S-methyltransferase
    Scheuermann, T.
    Hodsdon, M.
    Lolis, E.
    FEBS JOURNAL, 2008, 275 : 28 - 28
12345